Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes (Q40344166)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 December 2005

Language	Label	Description	Also known as
English	Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes	scientific article published on 2 December 2005

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes (English)

1 reference

Europe PubMed Central

19 September 2017

toll-like receptor

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Kazuhito Naka

1

1 reference

Europe PubMed Central

19 September 2017

Hiromichi Dansako

2

1 reference

Europe PubMed Central

19 September 2017

Naoya Kobayashi

3

1 reference

Europe PubMed Central

19 September 2017

Masanori Ikeda

4

1 reference

Europe PubMed Central

19 September 2017

Nobuyuki Kato

5

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

2 December 2005

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

346

1 reference

Europe PubMed Central

19 September 2017

348-362

1 reference

Europe PubMed Central

19 September 2017

2

1 reference

Europe PubMed Central

19 September 2017

v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

The natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C virus proteins exhibit conflicting effects on the interferon system in human hepatocyte cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Genomic instability in chronic viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Viruses and interferon: a fight for supremacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Identification of a C-Terminal Regulatory Motif in Hepatitis C Virus RNA-Dependent RNA Polymerase: Structural and Biochemical Analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Activation of p53 tumor suppressor by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Toll-like receptors and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C virus core protein: intriguing properties and functional relevance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.10.023

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40344166&oldid=1895772119"